| Net Cash Provided by (Used in) Operating Activities |
$243,000,000 |
USD |
-7.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$71,000,000 |
USD |
-161% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$112,000,000 |
USD |
49% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
2,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
1 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$67,000,000 |
USD |
-55% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$731,000,000 |
USD |
3.1% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$51,000,000 |
USD |
31% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$218,000,000 |
USD |
1.9% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$11,000,000 |
USD |
57% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$720,000,000 |
USD |
13% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$134,000,000 |
USD |
13% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$177,000,000 |
USD |
-4.3% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$114,000,000 |
USD |
-21% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$1,184,000,000 |
USD |
48% |
Q2 2024 |
Q2 2024 |